These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus. Whitley RJ Pediatr Infect Dis J; 1989 Sep; 8(9):584-5. PubMed ID: 2552389 [No Abstract] [Full Text] [Related]
4. Comparative use of adenine arabinoside and adenine arabinoside monophosphate in varicella and disseminated zoster in immunosuppressed patients. Vilde JL; Bricaire F; Huchon A; Brun-Vezinet F J Med Virol; 1983; 12(2):149-53. PubMed ID: 6194253 [TBL] [Abstract][Full Text] [Related]
5. [Preliminary clinical experiences with adenine arabinoside monophosphate (ARA-AMP) in encephalitis due to viruses of the herpes group and varicella/zoster infections (author's transl)]. Sauer O; Werner GT; Schneider H; Lenard HG; von Haselberg L; Nettesheim HJ Klin Padiatr; 1979 Nov; 191(6):566-71. PubMed ID: 92592 [TBL] [Abstract][Full Text] [Related]
6. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. Whitley RJ; Ch'ien LT; Dolin R; Galasso GJ; Alford CA N Engl J Med; 1976 May; 294(22):1193-9. PubMed ID: 177866 [TBL] [Abstract][Full Text] [Related]
7. Vidarabine therapy for severe herpesvirus infections. An unusual syndrome of chronic varicella and transient immunologic deficiency. Aronson MD; Phillips CF; Gump DW; Albertini RJ; Phillips CA JAMA; 1976 Mar; 235(13):1339-42. PubMed ID: 175176 [TBL] [Abstract][Full Text] [Related]
8. Varicella in patients infected with the human immunodeficiency virus. Perronne C; Lazanas M; Leport C; Simon F; Salmon D; Dallot A; Vildé JL Arch Dermatol; 1990 Aug; 126(8):1033-6. PubMed ID: 2166482 [TBL] [Abstract][Full Text] [Related]
9. [Preliminary animal experimental results and clinical experiences with the antiviral agent adenine arabinoside monophosphate in encephalitis from herpes group and varicella-zoster infections]. Sauer O; Huth E; Lenard HG; Schneider H; von Haselberg L; Nettesheim HJ; Werner GT Monatsschr Kinderheilkd (1902); 1980 May; 128(5):248-50. PubMed ID: 6158680 [No Abstract] [Full Text] [Related]
10. The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient. Kobayashi H; Yoshida Y; Komoshita T; Suma H; Hosokawa Y; Hirose Y; Sugimoto T; Mokuda S; Hirata S; Sugiyama E Intern Med; 2022 Jun; 61(11):1785-1788. PubMed ID: 34776482 [TBL] [Abstract][Full Text] [Related]
11. Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients. Vildé JL; Bricaire F; Leport C; Renaudie M; Brun-Vézinet F J Med Virol; 1986 Oct; 20(2):127-34. PubMed ID: 3534140 [TBL] [Abstract][Full Text] [Related]
13. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression. Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096 [TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment. Balfour HH Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447 [TBL] [Abstract][Full Text] [Related]
15. [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old]. Folatre I; Zolezzi P; Schmidt D; Marín F; Täger M Rev Med Chil; 2003 Jul; 131(7):759-64. PubMed ID: 14513696 [TBL] [Abstract][Full Text] [Related]
16. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Breuer J; Whitley R Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892 [TBL] [Abstract][Full Text] [Related]